MR spectroscopy and CEST imaging
Revealing Cancer Metabolism In Vivo
Our research group develops non-invasive metabolic and molecular MR techniques using 1H and X nuclei, comprising high-resolution NMR spectroscopy (MRS) and MR spectroscopic imaging (MRSI) at ultra-high fields (B0 ≥ 7T) and chemical exchange saturation transfer (CEST) MR imaging. A particular clinical research focus is the molecular tissue characterization of brain tumors for the stratification of genetic subtypes and the assessment of response to therapies. Another focus is the development of novel imaging techniques for the improved molecular characterization of breast cancers.